Xichen Lin - 03 Jun 2024 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jun 2024, 19:38:50 UTC
Prior SEC filing
20 Mar 2024
Next SEC filing
03 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jun Yoon, Attorney-in-Fact

Key filing fact

Xichen Lin filed Form 4 for Structure Therapeutics Inc. (GPCR) on 05 Jun 2024.

Key facts

  • This page summarizes Xichen Lin's Form 4 filing for Structure Therapeutics Inc. (GPCR).
  • 6 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 05 Jun 2024, 19:38.

Change

  • Previous filing in this sequence was filed on 20 Mar 2024.
  • Current net transaction value: -$1,645,463.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GPCR transaction

Ordinary Shares

Options Exercise

Transaction value
$36,108
Shares
+106,200
Change %
+124%
Price
$0.3400*
Shares after
191,907
Date
03 Jun 2024
Ownership
Direct
GPCR transaction

Ordinary Shares

Conversion of derivative security

Transaction value
$0
Shares
-106,200
Change %
-55%
Price
$0.000000
Shares after
85,707
Date
03 Jun 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GPCR transaction Derivative

Share Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-106,200
Change %
-33%
Price
$0.000000
Shares after
213,800
Date
03 Jun 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
106,200
Exercise price
$0.3400
Footnotes
F2, F3
GPCR transaction Derivative

American Depositary Shares

Conversion of derivative security

Transaction value
$0
Shares
+35,400
Change %
Price
$0.000000
Shares after
35,400
Date
03 Jun 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
106,200
Exercise price
Footnotes
F4, F5
GPCR transaction Derivative

American Depositary Shares

Sale

Transaction value
$796,500
Shares
-17,700
Change %
-50%
Price
$45.00
Shares after
17,700
Date
03 Jun 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
53,100
Exercise price
Footnotes
F4, F6
GPCR transaction Derivative

American Depositary Shares

Sale

Transaction value
$885,071
Shares
-17,700
Change %
-100%
Price
$50.00
Shares after
0
Date
03 Jun 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
53,100
Exercise price
Footnotes
F4, F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

The Ordinary Shares were converted into American Depositary Shares as reported in Table II above.

Footnote F2

1/4 of the shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.

Footnote F3

This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 106,200 Ordinary Shares.

Footnote F4

Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

Footnote F5

106,200 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 35,400 American Depositary Shares.

Footnote F6

The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023.

Footnote F7

The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .